03.27.25 -- CDMO Conflicts Within A Fragmented Landscape And Supplier Hygiene

Join us on March 31st to discover how Lonza's platform-based strategy ensures stability, efficacy, and quality in LNP Drug Products with nucleic acid payloads. Learn about critical process challenges in encapsulation, filtration, and aseptic filling, and how to proactively mitigate risks for successful GMP batch manufacturing. Register now for expert insights! Click here to learn more.

Can you recall the fundamentals of outsourcing development and manufacturing five or 10 years ago, if you were in the industry then? Our panel can, and it’s instructive to take the trip back in time.

You’ve got to give Towards Healthcare credit. They've the fortitude to publish a 10-year projection of how much development and manufacturing outsourcing will add up to globally. Interestingly, personalized medicine may play an outsized role in that growth. Chief Editor Louis Garguilo takes a deeper dive into the Pharmaceutical CDMO Market Companies, Advantages and Segmental Analysis.

By working with a single supplier that can handle the entire manufacturing value chain, companies can reduce risk, improve flexibility, and accelerate their time to market.

A proactive approach to packaging development can ultimately ensure a smoother launch. Explore five key considerations when selecting components for your injectable drug product.

Review groundbreaking platforms for designing bispecific antibodies that enhance cancer targeting and immune recruitment, setting new standards in cancer treatment efficacy.

Developing microbial fermentation depends on optimizing growth and expression phases through efficient oxygen transfer, fine-tuning nutrient delivery, and induction of protein expression.

CDMOs are playing a critical role in the global effort to prepare for future pandemics. Learn how innovative strategies and flexible platforms are helping to ensure a swift and effective response plan.

Although inspection and audit processes have evolved, you can still effectively navigate and manage them within your organization. Consider four solutions to address audit and inspection pain points.

The pre-filled syringe space is one of the fastest-growing pharma sectors, offering greater patient safety and lower manufacturing costs. But pre-filled doesn’t translate to easily filled.

Examine how a partner with extensive capabilities and expertise adds value to drug development and helps to solve complex formulation, analytical, and manufacturing challenges our clients face.

As the field of biologics increases its focus on identifying new diseases to target and novel constructs to treat them, innovative administration devices are once again in the spotlight.

Uncover how contract manufacturers are doubling down on growth and expanding capabilities in combination product and drug-fill/finish manufacturing to meet the evolving needs of the biotech industry.

Scaling your drug product from concept to commercial supply requires having the expertise to ask the right questions about your end goals, from the start.

This presentation will showcase our extensive range of offerings, including our advanced high-speed, multi-purpose Fill/Finish line designed for vials, syringes, and cartridges.

We now serve more than half of the world’s leading biopharmaceutical companies, sharing their mission to expedite patient access to life-saving biologics.

Join Rose Rhomberg, Senior Business Development Director, as she showcases Cytovance’s microbial and mammalian capabilities, along with our available manufacturing capacity.